Through this blog, we are pleased to provide you with regular updates on the NCI Cancer Genomics Cloud Pilots. In a recent post, George Komatsoulis discussed the NCI Board of Scientific Advisors’ unanimous approval of the project concept. He also announced the release of a Sources Sought notice, an opportunity for the technical community to share their capabilities as part of the government’s pre-solicitation market research.
To complement this call for technical input, we are now announcing an opportunity for the community to comment on priority scientific analyses and data that the cloud pilots should support. This opportunity follows on from the previous request for input, in which we received a number of examples of the types of scientific analyses that a Cancer Genomics Cloud pilot project should address. We invite you to comment on the priority and relevance of the examples we have received and ask that you also add to this list. Moreover, we are interested in learning about relevant cancer data sets you believe are essential for the pilot clouds to consider in addition to the core TCGA sequence, SNP, and clinical data in the current plans.
To provide a collaborative and transparent way for the community to comment on these important topics, we have decided to use the IdeaScale platform for this activity. IdeaScale has been used by other government agencies (e.g., FEMA) as well as other divisions of the NCI (e.g., the NCI Alliance for Nanotechnology in Cancer) to gather the public’s priorities on critical topics. IdeaScale allows you to enter a new “idea” (in this case, a scientific analysis or data set) as well as comment or vote on existing ideas, thereby allowing everyone to openly extend, improve, and even debate priorities.
The NCI Cancer Genomics Cloud Pilots IdeaScale site is now open for comment and we invite your input today. Please note that this is a Request for Information only and is solely for information and planning purposes. We plan to keep it open until a Broad Agency Announcement for the design and development of these systems is released. Indeed, it is our expectation that the offerors will refer to the scientific analysis and data priorities on the site to inform their proposals.
Juli Klemm, Ph.D., is Head, Cancer Biology and Genomics Section at the Center for Biomedical Informatics and Information Technology (CBIIT), National Cancer Institute (NCI). You may connect with Juli via LinkedIn.